Yonhap Infomax NewsJan 13
Lotte Biologics Co. has secured a contract manufacturing deal with Rakuten Medical Inc. for a head and neck cancer drug, aiming to expand its global CMO presence and build a supply chain from clinical trials to commercialization.
#YonhapInfomax #LotteBiologics #RakutenMedical #ContractManufacturing #HeadAndNeckCancer #SyracuseBioCampus #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=99683
Lotte Biologics Secures Contract Manufacturing Deal for Head and Neck Cancer Drug—Aims to Sustain Order Momentum

Lotte Biologics Co. has secured a contract manufacturing deal with Rakuten Medical Inc. for a head and neck cancer drug, aiming to expand its global CMO presence and build a supply chain from clinical trials to commercialization.

Yonhap Infomax
Yonhap Infomax NewsOct 10
Rakuten Medical is advancing its light-based Alluminox cancer therapy, aiming to minimize side effects and improve patient quality of life, with plans for global expansion and entry into the South Korean market through partnerships with Lotte Biologics and local ventures.
#YonhapInfomax
#RakutenMedical #Alluminox #CancerTherapy #LotteBiologics #Photoimmunotherapy
#Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=84992
Rakuten Medical CEO – 'Maintaining Quality of Life for Cancer Patients with Light-Based Therapy… Eyes on Korean Market'

Rakuten Medical is advancing its light-based Alluminox cancer therapy, aiming to minimize side effects and improve patient quality of life, with plans for global expansion and entry into the South Korean market through partnerships with Lotte Biologics and local ventures.

Yonhap Infomax